Latest Articles
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... - Medical Dialogues
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... Medical Dialogues
Published: July 2, 2025, 11:31 a.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer - Medical Dialogues
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer Medical Dialogues
Published: July 2, 2025, 6:31 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution - Business Standard
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution Business Standard
Published: July 2, 2025, 4:56 a.m.
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer - Republic World
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer Republic World
Published: July 1, 2025, 2:59 p.m.
Key Trend In The Leuprolide Acetate Market In 2025: Innovative Drug Delivery Formulations Enhance Patient - EIN News
Key Trend In The Leuprolide Acetate Market In 2025: Innovative Drug Delivery Formulations Enhance Patient EIN News
Published: July 1, 2025, 11:02 a.m.
Exploring the Immune System's Role in Endometriosis: Insights Into Pathogenesis, Pain, and Treatment.
Endometriosis is a common gynecological condition that usually affects women during their reproductive years. The main goal of this narrative review is to understand the role of the innate and …
Published: July 1, 2025, midnight
Unraveling the Contribution of Estrobolome Alterations to Endometriosis Pathogenesis.
Endometriosis (EMS) is a long-term inflammatory disease. It represents one of the most prevalent gynecological conditions, impacting an estimated 5% of reproductive women. Therefore, endometriosis contributes to substantial worldwide health …
Published: July 1, 2025, midnight
Beyond energy: Why ubiquinol is gaining ground in women’s health formulations - NutraIngredients.com
Beyond energy: Why ubiquinol is gaining ground in women’s health formulations NutraIngredients.com
Published: June 30, 2025, 11:25 a.m.
Link copied to clipboard!